|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02269 WUXI BIO
Nominal 
14.860 -0.160 (-1.065%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 8,574,214 | 0.968% | 8,492,046 | 7,206,440 | 4,406,754 | 1,944,103 |
| Cost of Sales | (5,224,263) | 5.938% | (4,931,412) | (3,793,233) | (2,109,921) | (1,156,797) |
| Gross Profit | 3,349,951 | -5.917% | 3,560,634 | 3,413,207 | 2,296,833 | 787,306 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (190,170) | 44.290% | (131,797) | (70,838) | (133,166) | (56,587) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | (1,101) | |
| Profit / (Loss) before Taxation | 2,008,377 | -20.585% | 2,528,976 | 2,930,135 | 2,058,228 | 705,106 | |
| Taxation | (228,067) | 19.334% | (191,116) | (308,910) | (175,450) | 25,598 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (281,230) | 295.069% | (71,185) | (86,161) | (40,638) | 5,409 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,499,080 | -33.864% | 2,266,675 | 2,535,064 | 1,842,140 | 736,113 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (123,922) | -- | 3,976 | (21,343) | (5,415) | (6,968) |
| Depreciation & Amortisation | 783,792 | 17.248% | 668,491 | 500,955 | 332,131 | 213,861 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 37.000 | -32.727% | 55.000 | 61.000 | 44.000 | 19.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 9.789 | -- | 8.883 | 8.083 | 7.839 | 3.470 |
| Remarks: | Real time quote last updated: 18/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,499,080 |
| %Change | -33.864% |
| EPS / (LPS) | RMB 0.370 |
| NBV Per Share (¥) | RMB 9.789 |